Cotinga Pharmaceuticals Inc. (COTQF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2018 | -83.84 Thousand USD | 50.87% |
| 2017 | -170.67 Thousand USD | 6.45% |
| 2016 | -182.43 Thousand USD | -5.68% |
| 2015 | -172.63 Thousand USD | 82.95% |
| 2014 | -1.01 Million USD | -21.15% |
| 2013 | -835.54 Thousand USD | -32.96% |
| 2012 | -628.39 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2019 Q2 | -120.35 USD | 4.89% |
| 2019 Q3 | -108.95 USD | 9.48% |
| 2019 Q1 | -126.54 USD | -21.76% |
| 2018 Q4 | -103.92 USD | -93.54% |
| 2018 FY | -83.84 Thousand USD | 50.87% |
| 2018 Q1 | -295.70 USD | 26.79% |
| 2018 Q2 | -101.69 USD | 65.61% |
| 2018 Q3 | -53.70 USD | 47.19% |
| 2017 Q3 | -455.76 USD | 40.91% |
| 2017 Q2 | -771.34 USD | -48.14% |
| 2017 Q1 | -520.69 USD | -6.13% |
| 2017 FY | -170.67 Thousand USD | 6.45% |
| 2017 Q4 | -403.89 USD | 11.38% |
| 2016 Q4 | -490.59 USD | 1.38% |
| 2016 Q3 | -497.44 USD | 5.25% |
| 2016 FY | -182.43 Thousand USD | -5.68% |
| 2016 Q2 | -525.00 USD | -19.27% |
| 2016 Q1 | -440.17 USD | -36.76% |
| 2015 FY | -172.63 Thousand USD | 82.95% |
| 2015 Q4 | -321.86 USD | -23.13% |
| 2015 Q3 | -261.40 USD | -4.4% |
| 2015 Q2 | -250.39 USD | -12.08% |
| 2015 Q1 | -223.41 USD | 32.74% |
| 2014 FY | -1.01 Million USD | -21.15% |
| 2014 Q3 | -251.59 USD | 10.05% |
| 2014 Q2 | -279.68 USD | -61.15% |
| 2014 Q1 | -173.55 USD | 63.69% |
| 2014 Q4 | -332.13 USD | -32.02% |
| 2013 Q4 | -478.04 USD | -242.12% |
| 2013 FY | -835.54 Thousand USD | -32.96% |
| 2013 Q2 | -105.88 USD | 13.51% |
| 2013 Q1 | -122.41 USD | -142.22% |
| 2013 Q3 | -139.73 USD | -31.97% |
| 2012 FY | -628.39 Thousand USD | 0.0% |
| 2012 Q4 | -50.54 USD | 68.12% |
| 2012 Q2 | -195.52 USD | 0.0% |
| 2012 Q3 | -158.53 USD | 18.92% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Arch Therapeutics, Inc. | -2439.00 USD | -3337.843% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 100.716% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 73.757% |
| Rebus Holdings, Inc. | - USD | Infinity% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 100.07% |
| Qrons Inc. | - USD | Infinity% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 99.675% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | -73.748% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 32.516% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 100.559% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | 2803.063% |
| Institute of Biomedical Research Corp. | - USD | Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | 100.856% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | 227.57% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | -145.531% |
| Mesoblast Limited | -35.16 Million USD | 99.762% |
| Marizyme, Inc. | 457.7 Thousand USD | 118.32% |
| Genus plc | 178.7 Million USD | 100.047% |
| VioQuest Pharmaceuticals, Inc. | - USD | Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 100.038% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | 234.749% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | 120.443% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | -662.264% |
| ContraFect Corporation | -154 Thousand USD | 45.553% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | -67.698% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | 209.234% |
| IMV Inc. | -962.29 Thousand USD | 91.287% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 78.362% |
| MultiCell Technologies, Inc. | 49.32 USD | 170110.138% |
| ONE Bio Corp. | 20.12 Million USD | 100.417% |
| Accustem Sciences Inc. | - USD | Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 100.208% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | 271.47% |
| Q BioMed Inc. | -8988.00 USD | -832.899% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 100.297% |
| Mosaic ImmunoEngineering Inc. | - USD | Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | -443.627% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 100.189% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 92.655% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | 219.784% |
| GlobeStar Therapeutics Corporation | - USD | Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | -1593.235% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | 159.679% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 14.014% |
| GB Sciences, Inc. | -624.00 USD | -13337.34% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 2.533% |
| HST Global, Inc. | - USD | Infinity% |
| CSL Limited | 7.56 Billion USD | 100.001% |
| Wesana Health Holdings Inc. | - USD | Infinity% |
| Halberd Corporation | -208.00 USD | -40212.019% |
| Enzolytics Inc. | 30.7 Thousand USD | 373.053% |
| Agentix Corp. | - USD | Infinity% |
| Resverlogix Corp. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | 117.38% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | 1.1 Billion USD | 100.008% |
| Enzon Pharmaceuticals, Inc. | - USD | Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 83.703% |
| RespireRx Pharmaceuticals Inc. | - USD | Infinity% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | 113.581% |
| Zenith Capital Corp. | - USD | Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 100.02% |
| Ember Therapeutics, Inc. | - USD | Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | -846.804% |
| WPD Pharmaceuticals Inc. | - USD | Infinity% |
| Kadimastem Ltd | -630.13 Thousand USD | 86.694% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | 108.487% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 100.872% |
| BioStem Technologies, Inc. | 15.42 Million USD | 100.544% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | - USD | Infinity% |
| LadRx Corporation | -11.83 Thousand USD | -608.483% |
| Cell Source, Inc. | - USD | Infinity% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 147.49% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 147.49% |
| NovAccess Global Inc. | - USD | Infinity% |
| Affymax, Inc. | 1.35 Million USD | 106.178% |
| Itoco Inc. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | - USD | Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | Infinity% |
| Mobile Lads Corp. | - USD | Infinity% |
| CytoDyn Inc. | -29 Thousand USD | -189.134% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | - USD | Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | 118.631% |
| SYBLEU INC | 11.69 Thousand USD | 816.903% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 101.82% |
| Bioxytran, Inc. | -8285.00 USD | -912.058% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | - USD | Infinity% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | - USD | Infinity% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | - USD | Infinity% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | - USD | Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 77.52% |
| Neutra Corp. | 14.33 Thousand USD | 684.925% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -2.255% |
| PureTech Health plc | -1.6 Million USD | 94.769% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 91.625% |
| IXICO plc | 3.27 Million USD | 102.564% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 87.918% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 95.318% |
| CSL Limited | 7.7 Billion USD | 100.001% |
| Cellectis S.A. | 18 Thousand USD | 565.828% |